Merck & Co. Inc. buy Guggenheim
Start price
12.02.25
/
50%
€83.40
Target price
12.02.26
€110.77
Performance (%)
-10.90%
Price
25.08.25
€73.50
Summary
This prediction is currently active. The prediction for Merck & Co. Inc. disappoints with a performance of -10.90%. Dividends of €0.81 are taken into consideration when calculating the performance. This prediction currently runs until 12.02.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Merck & Co. Inc. | 1.801% | 1.801% |
| iShares Core DAX® | -0.347% | -0.149% |
| iShares Nasdaq 100 | -0.687% | 1.850% |
| iShares Nikkei 225® | -2.075% | 3.770% |
| iShares S&P 500 | 0.351% | 1.988% |
Comments by Guggenheim for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) had its price target lowered by analysts at Guggenheim from $122.00 to $115.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat
Stopped prediction by Guggenheim for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€94.60
06.11.24
06.11.24
€121.00
06.11.25
06.11.25
-20.63%
25.08.25
25.08.25
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€103.40
11.04.23
11.04.23
€113.61
11.04.24
11.04.24
13.73%
12.04.24
12.04.24